Related Experiment Video
Updated: Mar 22, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Cholecystitis and nephrotic syndrome complicating Epstein-Barr virus primary infection
Diana Rodà1, Malka Huici1, Sílvia Ricart1
1a Departments of Pediatrics.
Insights
Epstein-Barr virus (EBV) infection can cause severe illness in young children, even without immune disorders. Early corticosteroids and ganciclovir improved a case of severe EBV with multi-organ involvement.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Virology
Background:
- Epstein-Barr virus (EBV) typically causes mild, self-limiting infections in children under four.
- The host immune response significantly influences EBV clinical manifestations.
Observation:
- A 2-year-old boy presented with severe systemic inflammation and multi-organ dysfunction, including acute acalculous cholecystitis and renal failure.
- The patient had no identifiable immune disorder.
Findings:
- Treatment with corticosteroids and ganciclovir led to clinical improvement.
- This case highlights a severe EBV presentation in an immunocompetent child.
Implications:
- Severely symptomatic EBV infection warrants suspicion of primary immunodeficiency.
- Management strategies for severe EBV in immunocompetent hosts require further investigation.
Abstract:
Epstein-Barr virus (EBV) infection results in a spectrum of clinical manifestations. The host immune response to EBV plays a key role in the extent and degree of clinical features, which in children under 4 years of age are usually mild, non-specific and self-limiting. A 2-year-old boy in whom no known immune disorder could be found presented with acute acalculous cholecystitis, renal dysfunction with massive proteinuria, ascites, pleural effusion, minimal peripheral oedema and a severe systemic inflammatory response. Improvement occurred after initiation of corticosteroids and antiviral treatment with gancyclovir. In severely symptomatic or complicated EBV infection, a primary immunodeficiency must be suspected. If a primary immunodeficiency has been ruled out, the correct management of severe EBV infection in the immunocompetent host remains controversial.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Acute Pyelonephritis I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Pyelonephritis II: Diagnostic Studies and Management

